Receptor imaging application MR imaging liver cancer new contrast agent magnetic resonance MR imaging ASG receptors hepatocytes detection liver cancer rats Ultrasmall superparamagnetic mean size nm particles iron oxide USPIOs ASG receptors particles arabinogalactan AG Liver relaxation times single intravenous administration AG-USPIO equal dose conventional superparamagnetic liver MR contrast agent mean size nm Receptor affinity studies receptor-mediated attachment subsequent cellular endocytosis primary malignant hepatocellular carcinoma metastatic adenocarcinoma tumors surface ASG receptors malignant dedifferentiation vitro relaxation vivo MR experiments liver tumors USPIO hepatocytes mononuclear phagocytic system considerable dose reduction tumor-liver contrast distinction ASG-positive benign hepatocellular ASG-negative malignant hepatocellular tumors 